In further support, aberrantly increased expression of BCL6 correlates with increased MLL1 expression in both paediatric and adult MLL-rearranged B-cell acute lymphoblastic leukaemia (B-ALL) and defines a specific subset of patients with poor clinical outcome [84]. The gene discussed is BCL6; the disease is precursor B-cell acute lymphoblastic leukemia.